SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-000765
Filing Date
2024-01-04
Accepted
2024-01-04 16:15:18
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6576
  Complete submission text file 0001209191-24-000765.txt   8073
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900 BOSTON MA 02210
Business Address
Dunn Edmund (Reporting) CIK: 0001989401 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40522 | Film No.: 24512064